View all stories with this category.
The Avandia controversy poses some tough questions about how to balance risks, says Derek Lowe
Derek Lowe sets the record straight about pharmaceutical patents on traditional medicines
After months of bleak news about faltering pipelines and redundancies, it's time to find reasons to be cheerful about the drug industry, says Derek Lowe.
Derek Lowe wonders whether total synthesis is still worth the effort
Do the benefits of pharmaceutical company mergers really outweigh the costs, asks Derek Lowe
Derek Lowe wonders whether the secret recipe for scientific breakthroughs can be taught - and how much indigestion that recipe would cause in the boardroom
Derek Lowe looks at the recent failure of Pfizer's cholesterol drug, torcetrapib, and asks what it means for the future of pharmaceutical research
Derek Lowe looks at the story behind the growing investment by western companies in medicinal chemistry research in China
Derek Lowe wonders how to kill off bad drug candidates before companies invest valuable time and money in them
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud